Company profile
Apyx Medical Corporation
NASDAQ: APYX · Healthcare · Medical - Specialties
#425 of 1,418 Healthcare companies by revenue55th-percentile growth
EA Score
64CFH 56DQ 81GM 57SS 58
v0.1 · 65/100 weight · provisional
↑ disclosure history, filing timeliness · ↓ listing tenure, return on equity
Methodology →Revenue TTM
$55.9M
Rev growth YoY (TTM)
+18.2%
Net income (FY)
-$11.2M
Employees
205
as of 2026-08-14
Market cap
$128.0M
as of 2026-08-14
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$52.8M$52.8M2025
Net income-$11.2M-$11.2M2025
Operating income-$6.4M-$6.4M2025
Total assets$66.8M$66.8M2025
Liabilities$52.0M$52.0M2025
Equity$14.5M$14.5M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
OEM100%
By geography
UNITED STATES73%
Non-US27%
The read
What is Apyx Medical Corporation’s revenue?
Apyx Medical Corporation booked $52.8M in FY2025 revenue, growing 9.9% year over year — about the middle of the pack among Healthcare companies we track, at a -21.2% net margin.
Peers · Healthcare
Q32 Bio Inc.72BInvivyd, Inc.41DRegional Health Properties, Inc.67BProtalix BioTherapeutics, Inc.66BIRIDEX Corporation55C1CM Inc.70BNeighbors
Pinellas →Key facts
CEOCharles D. Goodwin
SectorHealthcare
IndustryMedical - Specialties
HeadquartersClearwater, FL
ExchangeNASDAQ: APYX
Employees205
IPO date2019-01-02
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.